// company-profile

Neuphoria Therapeutics Inc.

NEUP
ExchangeNasdaqSectorPharmaceutical PreparationsInc.C3Filings12Insiders7
// api This Neuphoria Therapeutics Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for NEUP in the last 90 days.

Institutional Ownership

Top 13F-HR holders of Neuphoria Therapeutics Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$6.6M
QoQ change
+18.1%
Reporting period
2026-03-31
#1
Lynx1 Capital Management LP
CIK 1910456
$3.6M
875K shares
#2
AdvisorShares Investments LLC
CIK 1425930
$632,344
155K shares
#3
Shay Capital LLC
CIK 1723643
$614,611
151K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jan 20, 2026Wilson David IanNEUP
Award
8,537$0.00$0K
Jan 20, 2026Ryan JaneNEUP
Award
8,537$0.00$0K
Jan 20, 2026Fisher AlanNEUP
Award
17,073$0.00$0K
Jan 20, 2026Davies Peter Miles WinstonNEUP
Award
8,537$0.00$0K
Oct 21, 2025Lynx1 Capital Management LPNEUP
Purchase
639,110$5.14$3.28M

6 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.